Ilan Weisberg

2.9k total citations · 1 hit paper
45 papers, 1.6k citations indexed

About

Ilan Weisberg is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Ilan Weisberg has authored 45 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 20 papers in Hepatology and 13 papers in Surgery. Recurrent topics in Ilan Weisberg's work include Liver Disease Diagnosis and Treatment (17 papers), Liver Disease and Transplantation (10 papers) and Hepatitis C virus research (9 papers). Ilan Weisberg is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Liver Disease and Transplantation (10 papers) and Hepatitis C virus research (9 papers). Ilan Weisberg collaborates with scholars based in United States, Canada and China. Ilan Weisberg's co-authors include Rima Rozen, Sahar Sibani, Benedicte Christensen, Pamela V. Tran, Ira M. Jacobson, Timothy A. Garrow, Sara Lewis, Nelson Valentin, Andrew P. Breksa and Isabelle Morin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Medicine.

In The Last Decade

Ilan Weisberg

33 papers receiving 1.5k citations

Hit Papers

A Second Genetic Polymorphism in Methylenetetrahydrofolat... 1998 2026 2007 2016 1998 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilan Weisberg United States 14 1.1k 427 353 303 245 45 1.6k
Sarah Westlake United Kingdom 7 402 0.4× 135 0.3× 91 0.3× 140 0.5× 167 0.7× 8 993
Keith K. Lau United States 16 151 0.1× 170 0.4× 271 0.8× 161 0.5× 140 0.6× 55 1.2k
Markus J. Kemper Germany 23 143 0.1× 170 0.4× 221 0.6× 397 1.3× 184 0.8× 65 1.9k
Sergio Ferrazzani Italy 21 327 0.3× 148 0.3× 241 0.7× 73 0.2× 645 2.6× 86 1.6k
W.B.J. Gerrits Netherlands 13 697 0.7× 343 0.8× 539 1.5× 58 0.2× 43 0.2× 24 1.3k
Serena M. Passamonti Italy 22 154 0.1× 245 0.6× 637 1.8× 148 0.5× 44 0.2× 50 1.6k
Jakob Lauritsen Denmark 25 248 0.2× 888 2.1× 104 0.3× 373 1.2× 384 1.6× 96 1.9k
Paul T. McEnery United States 28 116 0.1× 388 0.9× 150 0.4× 199 0.7× 383 1.6× 64 2.0k
K. Mikkelsen Norway 25 1.5k 1.4× 163 0.4× 538 1.5× 136 0.4× 22 0.1× 56 2.1k
Fabrizio Fabris Italy 25 242 0.2× 542 1.3× 1.1k 3.0× 333 1.1× 44 0.2× 102 2.0k

Countries citing papers authored by Ilan Weisberg

Since Specialization
Citations

This map shows the geographic impact of Ilan Weisberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilan Weisberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilan Weisberg more than expected).

Fields of papers citing papers by Ilan Weisberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilan Weisberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilan Weisberg. The network helps show where Ilan Weisberg may publish in the future.

Co-authorship network of co-authors of Ilan Weisberg

This figure shows the co-authorship network connecting the top 25 collaborators of Ilan Weisberg. A scholar is included among the top collaborators of Ilan Weisberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilan Weisberg. Ilan Weisberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weisberg, Ilan, et al.. (2024). Sa1097 A RETROSPECTIVE ANALYSIS OF GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONISTS ON BOWEL PREPARATION EFFICACY IN COLONOSCOPIES. Gastroenterology. 166(5). S–336. 1 indexed citations
3.
Weisberg, Ilan, et al.. (2023). Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease Is Independently Associated With Reduced Renal Function. SHILAP Revista de lepidopterología. 3(1). 122–127. 5 indexed citations
4.
Dinani, Amreen, et al.. (2022). The Delta Delta: Gaps in screening and patient assessment for hepatitis D virus infection. Journal of Viral Hepatitis. 30(3). 195–200. 20 indexed citations
5.
Weisberg, Ilan, et al.. (2020). Risk factors and incidence of 90-day readmission for diverticulitis after an acute diverticulitis index admission. International Journal of Colorectal Disease. 36(2). 347–352. 6 indexed citations
6.
Valentin, Nelson, et al.. (2018). The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology. 30(10). 1187–1193. 38 indexed citations
7.
Weisberg, Ilan, et al.. (2017). Viral hepatitis screening in transgender patients undergoing gender identity hormonal therapy. European Journal of Gastroenterology & Hepatology. 29(11). 1215–1218. 11 indexed citations
8.
Weisberg, Ilan & Ira M. Jacobson. (2017). A pangenotypic, single tablet regimen of sofosbuvir/velpatasvir for the treatment of chronic hepatitis C infection. Expert Opinion on Pharmacotherapy. 18(5). 535–543. 21 indexed citations
9.
Weisberg, Ilan & Ira M. Jacobson. (2017). Primer on Hepatitis C Virus Resistance to Direct-Acting Antiviral Treatment. Clinics in Liver Disease. 21(4). 659–672. 5 indexed citations
10.
Teplinsky, Eleonora, Ilan Weisberg, Martin Wolff, et al.. (2013). Fatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature. Breast Cancer Research and Treatment. 141(2). 167–172. 15 indexed citations
11.
Kesar, Varun, et al.. (2013). Mitragyna Speciosa (Kratom)-Induced Cholestatic Hepatitis. The American Journal of Gastroenterology. 108. S139–S139. 1 indexed citations
12.
Weisberg, Ilan & Ira M. Jacobson. (2010). Cardiovascular Diseases and the Liver. Clinics in Liver Disease. 15(1). 1–20. 38 indexed citations
13.
Weisberg, Ilan, et al.. (2009). 234 THE ROLE OF SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) IN HEPATIC ENCEPHALOPATHY. Journal of Hepatology. 50. S94–S95. 2 indexed citations
15.
Goldberg, David, Ilan Weisberg, David Diuguid, et al.. (2008). Worth a Second Look. The American Journal of Medicine. 122(1). 24–26. 1 indexed citations
16.
Weisberg, Ilan, Robert S. Brown, & Samuel H. Sigal. (2007). Hepatitis B and End-Stage Liver Disease. Clinics in Liver Disease. 11(4). 893–916. 13 indexed citations
17.
Sibani, Sahar, Daniel Leclerc, Ilan Weisberg, et al.. (2003). Characterization of mutations in severe methylenetetrahydrofolate reductase deficiency reveals an FAD-responsive mutation. Human Mutation. 21(5). 509–520. 41 indexed citations
18.
Morin, Isabelle, Robert W. Platt, Ilan Weisberg, et al.. (2003). Common variant in betaine‐homocysteine methyltransferase (BHMT) and risk for spina bifida. American Journal of Medical Genetics Part A. 119A(2). 172–176. 59 indexed citations
19.
Weisberg, Ilan, Eric Park, Karla V. Ballman, et al.. (2003). Investigations of a common genetic variant in betaine–homocysteine methyltransferase (BHMT) in coronary artery disease. Atherosclerosis. 167(2). 205–214. 75 indexed citations
20.
Weisberg, Ilan, Pamela V. Tran, Benedicte Christensen, Sahar Sibani, & Rima Rozen. (1998). A Second Genetic Polymorphism in Methylenetetrahydrofolate Reductase (MTHFR) Associated with Decreased Enzyme Activity. Molecular Genetics and Metabolism. 64(3). 169–172. 1081 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026